VERTEX PHARMACEUTICALS INC / MA reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Boston, MA
SEC filing record 1 source field available
Fiscal year end
31 December
VERTEX PHARMACEUTICALS INC / MA has filed 3,632 SEC EDGAR filings since 15 Feb 1995

SEC filing history

Showing 401-425 of 1,000 matching filings.

Per page
25
Current page
17
4

FORM 4

Filing date
03 May 2024
Reporting date
01 May 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
03 May 2024
Reporting date
01 May 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
03 May 2024
Reporting date
01 May 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
03 May 2024
Reporting date
01 May 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
03 May 2024
Reporting date
01 May 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
03 May 2024
Reporting date
01 May 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
03 May 2024
Reporting date
01 May 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 000-19319

144 filing

Filing date
02 May 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC TO-T

SC TO-T

Filing date
22 Apr 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
17 Apr 2024
Reporting date
15 Apr 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
PX14A6G File 000-19319

PX14A6G filing

Filing date
16 Apr 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC TO-C

SC TO-C

Filing date
11 Apr 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC TO-C File 005-42126

SC TO-C

Filing date
11 Apr 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC TO-C

SC TO-C

Filing date
10 Apr 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-42126

SEC SCHEDULE 13G

Filing date
10 Apr 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
ARS File 000-19319

VERTEX PHARMACEUTICALS INC - ARS

Filing date
04 Apr 2024
Reporting date
31 Dec 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 000-19319

VERTEX PHARMACEUTICALS INC - DEFA14A

Filing date
04 Apr 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 000-19319

VERTEX PHARMACEUTICALS INC - DEF 14A

Filing date
04 Apr 2024
Reporting date
15 May 2023
Next action
Verify source filing
4

FORM 4

Filing date
03 Apr 2024
Reporting date
01 Apr 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
27 Feb 2024
Reporting date
23 Feb 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
27 Feb 2024
Reporting date
23 Feb 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
27 Feb 2024
Reporting date
23 Feb 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
27 Feb 2024
Reporting date
23 Feb 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
27 Feb 2024
Reporting date
23 Feb 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .